Company Search:
Advanced Search
Sponsored Links
GW Pharmaceuticals PLC Company Snapshot
GW Pharmaceuticals PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC with three other companies in this sector in the United Kingdom: Genedrive PLC (2016 sales of £5.06 million [US$6.18 million] of which 40% was Preclinical Research services), Bioventix Plc (£5.52 million [US$6.74 million] ), and Vernalis Plc (£12.03 million [US$14.69 million] of which 67% was Collaborative).

Sales Analysis. GW Pharmaceuticals PLC reported sales of £10.32 million (US$12.59 million) for the fiscal year ending September of 2016. This represents a sharp decrease of 63.9% versus 2015, when the company's sales were £28.54 million. Contributing to the drop in overall sales was the 84.3% decline in Sativex R&d, from £22.28 million to £3.50 million. There were also decreases in sales in Pipeline R&d (down 37.0% to £337,000.00 ) . However, these declines were partially offset by the increase in sales of Commercial (up 13.1% to £6.48 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
GW Pharmaceuticals PLC
  Stock Performance Chart for GW Pharmaceuticals PLC
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 735.00p
(Figures in Pounds Sterling)
1 Week -8.1%   13 Weeks -2.1%  
4 Weeks 42.3%   52 Weeks 61.7%  
GW Pharmaceuticals PLC Key Data:
  Ticker: GWP Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 10,315,000
(Year Ending Jan 2017).
Employees: 496
  Currency: Pounds Sterling Market Cap: 2,220,384,572
  Fiscal Yr Ends: September Shares Outstanding: 302,093,139
  Share Type: Ordinary Closely Held Shares: 21,371,673
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.